Basic information Safety Supplier Related

PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]-

Basic information Safety Supplier Related

PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]- Basic information

Product Name:
PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]-
Synonyms:
  • PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]-
  • 2,2'-Sulfonylbis(3,4,6-trichlorophenol)
  • p38 MAP Kinase Inhibitor IV
  • p38 MAPK Inhibitor IV
  • p38 MAP Kinase Inhibitor IV - CAS 1638-41-1 - Calbiochem
  • Phenol, 3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)sulfonyl]-
  • p38 MAP Kinase Inhibitor IV (B10)
  • p38 MAP Kinase Inhibitor IV,p-38 MAP Kinase Inhibitor IV
CAS:
1638-41-1
MF:
C12H4Cl6O4S
MW:
456.94
Mol File:
1638-41-1.mol
More
Less

PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]- Chemical Properties

Melting point:
244-245 °C(Solv: ethyl acetate (141-78-6))
Boiling point:
590.0±50.0 °C(Predicted)
Density 
1.854±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: soluble5mg/mL, clear (warmed)
pka
2.43±0.50(Predicted)
form 
powder
color 
white to beige
More
Less

Safety Information

WGK Germany 
3
More
Less

PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]- Usage And Synthesis

Uses

p38 MAP Kinase Inhibitor IV is an ATP-competitive p38α/β MAPK inhibitor.

Uses

p38 MAP Kinase Inhibitor IV has been used for blocking p38α kinase activation in order to examine if HOXB7 is involved in the regulation of migration and proliferation process via AKT/MAPK signaling.

General Description

A cell-permeable symmetrical sulfone compound that acts as a potent and ATP-competitive inhibitor of p38α/β MAPK (IC50 = 130 and 550 nM, respectively), while exihibiting much reduced activity (≤23% inhibition at 1 μM) against p38γ/δ, ERK1/2, and JNK1/2/3. Shown to be more effective than SB 203850 (Cat. Nos. 559389, 559395, and 559398) in inhibiting LPS-induced IL-1β release from hPBMC (100% vs. 50% inhibition with 100 μM respective inhibitor).

Biochem/physiol Actions

p38 MAP Kinase Inhibitor IV is an ATP-competitive inhibitor of p38α/β MAPK with IC50 values of 130 nM for p38α and 550 nM for p38β. It is much less active with ≤23% inhibition at 1 μM against p38γ/σ, ERK1/2, and JNK1/2/3. Shown to be more effective than SB 203580 in inhibiting LPS-induced IL-1β release from hPBMC (100% vs. 50% inhibition with 100 μM inhibitor). A recent study showed that p38 MAP Kinase Inhibitor IV could consistently and significantly enhance reprogramming and iPS cell generation from somatic cells.

PHENOL,2,2'-SULFONYLBIS[3,4,6-TRICHLORO]-Supplier

Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Pharmacodia (Beijing) Co.,Ltd
Tel
+86-400-851-9921
Email
sales@pharmacodia.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Lynnchem
Tel
86-(0)29-85992781 17792393971
Email
info@lynnchem.com